BrightPath Biotherapeutics Co.Ltd.’s (4594) Moving Averages Convergence Divergence (MACD) indicator is -2.17, suggesting BrightPath Biotherapeutics Co.Ltd. is a Sell.
BrightPath Biotherapeutics Co.Ltd.’s (4594) 20-Day exponential moving average is 40.13, while BrightPath Biotherapeutics Co.Ltd.’s (4594) share price is ¥39.00, making it a Sell.
BrightPath Biotherapeutics Co.Ltd.’s (4594) 50-Day exponential moving average is 44.10, while BrightPath Biotherapeutics Co.Ltd.’s (4594) share price is ¥39.00, making it a Sell.
BrightPath Biotherapeutics Co.Ltd.’s (4594) 10-Day exponential moving average is 38.70, while BrightPath Biotherapeutics Co.Ltd.’s (4594) share price is ¥39.00, making it a Sell.
BrightPath Biotherapeutics Co.Ltd.’s (4594) 100-Day exponential moving average is 47.44, while BrightPath Biotherapeutics Co.Ltd.’s (4594) share price is ¥39.00, making it a Sell.
BrightPath Biotherapeutics Co.Ltd.’s (4594) stock price is ¥39.00 and BrightPath Biotherapeutics Co.Ltd.’s (4594) 50-day simple moving average is 46.48, creating a Sell signal.
BrightPath Biotherapeutics Co.Ltd.’s (4594) stock price is ¥39.00 and BrightPath Biotherapeutics Co.Ltd.’s (4594) 100-day simple moving average is 47.84, creating a Sell signal.
BrightPath Biotherapeutics Co.Ltd.’s (4594) stock price is ¥39.00 and BrightPath Biotherapeutics Co.Ltd.’s (4594) 200-day simple moving average is 54.93, creating a Sell signal.